Immunic's IMU-935 Demonstrates Favorable Safety Profile In Phase I Trial
14/12 13:39
(RTTNews) - Immunic Inc. (IMUX), on Tuesday, announced positive results from Part A and Part B of its phase 1 clinical trial of IMU-935 in healthy human subjects....